...
首页> 外文期刊>Medical Physics >Dose to radiation therapists from activation at high-energy accelerators used for conventional and intensity-modulated radiation therapy.
【24h】

Dose to radiation therapists from activation at high-energy accelerators used for conventional and intensity-modulated radiation therapy.

机译:在传统和强度调制放射治疗中使用高能加速器激活后,向放射治疗师给药。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The increased beam-on times which characterize intensity-modulated radiation therapy (IMRT) could lead to an increase in the dose received by radiation therapists due to induced activity. To examine this, gamma ray spectrometry was used to identify the major isotopes responsible for activation at a representative location in the treatment room of an 18 MV accelerator (Varian Clinac 21EX). These were found to be 28Al, 56Mn, and 24Na. The decay of the dose rate measured at this location following irradiation was analyzed in terms of the known half-lives to yield saturation dose rates of 9.6, 12.4, and 6.2 microSv/h, respectively. A formalism was developed to estimate activation dose (microSv/week) due to successive patient irradiation cycles, characterized by the number of 18 MV fractions per week, F, the number of MU per fraction, M, the in-room time between fractions, td (min), and the treatment delivery time t'r (min). The results are represented by the sum of two formulas, one for the dose from 28Al 1.8 x 10(-3) F M (1-e(-03t'(r))/t'r and one for the dose from the other isotopes approximately 1.1 x 10(-6) F(1.7) Mt(d). For conventional therapy doses are about 60 microSv/week for an 18 MV workload of 60,000 MU/week. Irradiation for QA purposes can significantly increase the dose. For IMRT as currently practiced, lengthy treatment delivery times limit the number of fractions that can be delivered per week and hence limit the dose to values similar to those in conventional therapy. However for an IMRT regime designed to maximize patient throughput, doses up to 330 microSv/week could be expected. To reduce dose it is recommended that IMRT treatments should be delivered at energies lower than 18 MV, that in multienergy IMRT, high-energy treatments should be scheduled in the latter part of the day, and that equipment manufacturers should strive to minimize activation in the design of high-energy accelerators.
机译:表征强度调制放射治疗(IMRT)的增加的射线照射时间可能导致放射治疗师由于诱发的活动而增加剂量。为了对此进行检查,使用了伽马射线能谱法鉴定了在18 MV加速器(Varian Clinac 21EX)治疗室中代表性位置处引起活化的主要同位素。发现它们是28Al,56Mn和24Na。根据已知的半衰期分析了辐照后在此位置测得的剂量率的衰减,得出的饱和剂量率分别为9.6、12.4和6.2 microSv / h。建立了一种形式主义以估计由于连续的患者辐照周期而引起的激活剂量(microSv /周),其特征在于每周18个MV组分的数量F,每个组分的MU数量M,各组分之间的室内时间, td(min)和治疗时间t'r(min)。结果由两个公式的总和表示,一个公式来自28 Al 1.8 x 10(-3)FM的剂量(1-e(-03t'(r))/ t'r,另一个公式来自其他同位素的剂量大约1.1 x 10(-6)F(1.7)Mt(d)。对于常规治疗,每周18MV的工作量为60,000 MU /周,剂量约为60 microSv /周。为QA目的进行辐照可显着增加剂量。按照目前的做法,漫长的治疗时间限制了每周可输送的级分数量,因此将剂量限制在与传统疗法相似的水平;但是对于旨在最大程度提高患者通量的IMRT方案,剂量最高为330 microSv /为减少剂量,建议降低IMRT治疗能量应低于18 MV,在多能量IMRT中,应安排在当天下半年进行高能量治疗,设备制造商应努力使高能加速剂设计中的激活最小化ors。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号